---
figid: PMC9702353__fphar-13-956402-g005
pmcid: PMC9702353
image_filename: fphar-13-956402-g005.jpg
figure_link: /pmc/articles/PMC9702353/figure/F5/
number: FIGURE 5
figure_title: ''
caption: 'FLaAN/C inhibited NF-κB activation in mice with EAE. (A) Proteins levels
  of p-IκBα, IκBα, NF-κB-p65, and NF-κB-p-p65 in mouse spinal cord. (B) Representative
  immunofluorescence images of p65 in paraffin section of spinal cord tissue (scale
  bars:50 μm). Data are shown as means ± SD (n = 6 per group). *p < 0.05, **p < 0.01,
  ***p < 0.001; #p < 0.05, ##p < 0.01, ###p < 0.001. * vs. Control group; # vs. MOG
  group.'
article_title: Novel recombinant protein flagellin A N/C attenuates experimental autoimmune
  encephalomyelitis by suppressing the ROS/NF-κB/NLRP3 signaling pathway.
citation: Li Li, et al. Front Pharmacol. 2022;13:956402.
year: '2022'

doi: 10.3389/fphar.2022.956402
journal_title: Frontiers in Pharmacology
journal_nlm_ta: Front Pharmacol
publisher_name: Frontiers Media S.A.

keywords:
- FlaAN/C
- experimental autoimmune encephalomyelitis
- reactive oxygen species
- ROS/NF-κB/NLRP3 pathway
- pyroptosis

---
